Search research articles
Contact Us
Filters
Showing results (151-160 of 168) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summary
Peter J Houghton, Peter C Adamson, Susan Blaney, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of the National Cancer Institute
|
April 19, 2007
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas
Teri-T B Ngo, Tien Peng, Xing-Jie Liang, et al.
AJNR. American Journal of Neuroradiology
|
April 11, 2024
DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas
Joon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, et al.
Neuro-Oncology
|
August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology
|
June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
Phioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Neuro-Oncology
|
February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology
Gregory A Masters, Lada Krilov, Howard H Bailey, et al.
Neuro-Oncology
|
February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 168) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Testing of new agents in childhood cancer preclinical models: meeting summary
Peter J Houghton, Peter C Adamson, Susan Blaney, et al.
Neuro-Oncology
|
February 11, 2004
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study
Michael D Prados, W K A Yung, Kurt A Jaeckle, et al.
Journal of the National Cancer Institute
|
April 19, 2007
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas
Teri-T B Ngo, Tien Peng, Xing-Jie Liang, et al.
AJNR. American Journal of Neuroradiology
|
April 11, 2024
DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas
Joon Tae Kim, Se Jung Chris Chang, Arsalan Haghdel, et al.
Neuro-Oncology
|
August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.
Journal of Neuro-Oncology
|
June 30, 2009
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Andrew D Norden, Jeffrey J Raizer, Lauren E Abrey, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
Phioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Neuro-Oncology
|
February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology
Gregory A Masters, Lada Krilov, Howard H Bailey, et al.
Neuro-Oncology
|
February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Page
of 17